Celldex Therapeutics, Inc. (CLDX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Celldex Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.98x | -10.31x | -13.59x | -18.60x | -23.49x | -8.69x |
| P/B Ratio | 3.43x | 2.18x | 4.48x | 6.41x | 3.95x | 2.48x |
| P/S Ratio | 1204.09x | 231.80x | 279.16x | 886.63x | 356.16x | 70.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | -2229.8% | -1614.5% | -3389.9% | -1046.2% | -473.4% |
| Operating Margin | -19160.0% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% |
| Net Margin | -17253.3% | -2248.8% | -2054.8% | -4765.6% | -1516.0% | -805.9% |
| EBITDA Margin | -17028.0% | -2733.6% | -2020.0% | -4420.9% | -1420.8% | -615.3% |
| Liquidity | ||||||
| Current Ratio | 10.49x | 18.91x | 13.87x | 17.07x | 24.86x | 13.93x |
| Quick Ratio | 10.49x | 18.91x | 13.87x | 17.07x | 24.86x | 13.93x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..